Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1997-11-14
|
pubmed:abstractText |
Foreign DNA has been shown to impinge on immune cell function by an as yet unidentified mechanism. We and others have demonstrated that single-stranded (ss) DNA containing the motif CpG flanked by two 5' purines and two 3' pyrimidines are mitogenic for B cells and activate macrophages to release tumor necrosis factor-alpha, interferon-gamma, interleukin (IL)-6 or IL-12. Because of these pro-inflammatory responses we investigated if ssDNA would serve as a potential vaccine adjuvant. Here we show that CpG-containing oligonucleotides represent a powerful adjuvant for both humoral and cellular immune responses. When ssDNA was incorporated into inocula, specific antibody titers of the IgG2 isotype were enhanced by greater than 100-fold. Primary cytotoxic T lymphocyte responses generated to either unprocessed protein antigen or major histocompatibility complex class I-restricted peptide were exceedingly strong. Evidence is also provided that oligomers directly influenced T cell receptor-triggered T cell proliferation. Thus ssDNA oligomers may serve as inexpensive and safe vaccine adjuvants and, in addition, differential effects due to sequence may allow for directed responses.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Single-Stranded,
http://linkedlifedata.com/resource/pubmed/chemical/Dinucleoside Phosphates,
http://linkedlifedata.com/resource/pubmed/chemical/Oligodeoxyribonucleotides,
http://linkedlifedata.com/resource/pubmed/chemical/Ovalbumin,
http://linkedlifedata.com/resource/pubmed/chemical/cytidylyl-3'-5'-guanosine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0014-2980
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2340-4
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9341778-Adjuvants, Immunologic,
pubmed-meshheading:9341778-Animals,
pubmed-meshheading:9341778-B-Lymphocytes,
pubmed-meshheading:9341778-Base Sequence,
pubmed-meshheading:9341778-Cytotoxicity, Immunologic,
pubmed-meshheading:9341778-DNA, Single-Stranded,
pubmed-meshheading:9341778-Dinucleoside Phosphates,
pubmed-meshheading:9341778-Lymph Nodes,
pubmed-meshheading:9341778-Lymphocyte Activation,
pubmed-meshheading:9341778-Macrophages,
pubmed-meshheading:9341778-Mice,
pubmed-meshheading:9341778-Mice, Inbred C57BL,
pubmed-meshheading:9341778-Oligodeoxyribonucleotides,
pubmed-meshheading:9341778-Ovalbumin,
pubmed-meshheading:9341778-T-Lymphocytes
|
pubmed:year |
1997
|
pubmed:articleTitle |
CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants.
|
pubmed:affiliation |
Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Germany. tbl01bl@sunmail.lrz-muenchen.de
|
pubmed:publicationType |
Journal Article
|